ArticleAnnals of hepato-biliary-pancreatic surgery2025
Ex vivo liver resection and autotransplantation following transarterial chemoembolization and stereotactic body radiation therapy for advanced hepatocellular carcinoma.
Article in Annals of hepato-biliary-pancreatic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ex vivo liver resection and autotransplantation (ELRAT) is a technically demanding yet increasingly viable option for the treatment of otherwise unresectable tumors with vascular involvement. We describe the case of a 50-year-old female diagnosed with an extensive hepatocellular carcinoma involving the retrohepatic inferior vena cava (IVC) and major hepatic veins, deemed unresectable. After undergoing transarterial chemoembolization and stereotactic body radiation therapy, which resulted in significant tumor necrosis, reduction in lesion size, and a substantial decline in alpha-fetoprotein levels, the patient subsequently underwent ELRAT with IVC reconstruction. Although postoperative complications occurred, such as an incisional hernia and IVC stenosis that necessitated stent insertion, she has remained free of recurrence 24 months following surgery, demonstrating the potential of preoperative therapy to enhance ELRAT outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.